公开(公告)号：US12016685B2

公开(公告)日：2024-06-25

申请号：US16718046

申请日：2019-12-17

Applicant: DexCom, Inc.

Inventor： Apurv Ullas Kamath ,  Margaret A. Crawford ,  John Michael Gray ,  Hari Hampapuram ,  Matthew Lawrence Johnson ,  Subrai Girish Pai ,  Shawn Clay Sanders ,  Sumitaka Mikami

IPC: A61B5/1455 ,  A61B5/00 ,  A61B5/0205 ,  A61B5/024 ,  A61B5/11 ,  A61B5/145 ,  A61M5/172 ,  G06F11/10 ,  G16H10/60 ,  G16H40/67 ,  G16H20/17

CPC classification number: A61B5/14532 ,  A61B5/002 ,  A61B5/0022 ,  A61B5/1118 ,  A61B5/14546 ,  A61B5/1455 ,  A61B5/7267 ,  A61B5/742 ,  A61B5/7475 ,  A61M5/1723 ,  G06F11/1004 ,  G16H10/60 ,  G16H40/67 ,  A61B5/0205 ,  A61B5/02438 ,  A61B2560/0209 ,  A61B2560/0214 ,  G16H20/17

Abstract: Various examples are directed to systems and methods for measuring a parameter related to patient health. An analyte sensor system may detect that the analyte sensor system has been applied to a host and may store analyte data describing the host. The analyte sensor system may determine that sensor use at the analyte sensor system has terminated and upload stored analyte data to an upload computing device.

公开(公告)号：US11998322B2

公开(公告)日：2024-06-04

申请号：US16717834

申请日：2019-12-17

Applicant: DexCom, Inc.

Inventor： Apurv Ullas Kamath ,  Margaret A. Crawford ,  John Michael Gray ,  Hari Hampapuram ,  Matthew Lawrence Johnson ,  Subrai Girish Pai ,  Shawn Clay Sanders ,  Sumitaka Mikami

IPC: A61B5/145 ,  A61B5/00 ,  A61B5/11 ,  A61B5/1455 ,  A61M5/172 ,  G06F11/10 ,  G16H10/60 ,  G16H40/67 ,  A61B5/0205 ,  A61B5/024 ,  G16H20/17

CPC classification number: A61B5/14532 ,  A61B5/002 ,  A61B5/0022 ,  A61B5/1118 ,  A61B5/14546 ,  A61B5/1455 ,  A61B5/7267 ,  A61B5/742 ,  A61B5/7475 ,  A61M5/1723 ,  G06F11/1004 ,  G16H10/60 ,  G16H40/67 ,  A61B5/0205 ,  A61B5/02438 ,  A61B2560/0209 ,  A61B2560/0214 ,  G16H20/17

Abstract: Various examples are directed to systems and methods for patient monitoring. An example method comprises receiving an estimated glucose concentration level of the patient from a continuous glucose monitoring (CGM) system for a first time period. The method may also include receiving non-glucose information relating to the patient for the first time period and determining a relationship between the estimated glucose concentration level and the non-glucose information. The method may also include receiving non-glucose information relating to the patient for a second time period and determining diabetic information about the patient for the second time period based upon the determined relationship and the non-glucose information. The method may include electronically delivering a notification about the diabetic information.

公开(公告)号：US20200316296A1

公开(公告)日：2020-10-08

申请号：US16904454

申请日：2020-06-17

Applicant: DexCom, Inc.

Inventor： Anna Leigh Davis ,  Scott M. Belliveau ,  Naresh C. Bhavaraju ,  Leif N. Bowman ,  Rita M. Castillo ,  Alexandra Elena Constantin ,  Rian Draeger ,  Laura J. Dunn ,  Gary Brian Gable ,  Arturo Garcia ,  Thomas Hall ,  Hari Hampapuram ,  Christopher Robert Hannemann ,  Anna Claire Harley-Trochimczyk ,  Nathaniel David Heintzman ,  Andrea Jean Jackson ,  Lauren Hruby Jepson ,  Apurv Ullas Kamath ,  Katherine Yerre Koehler ,  Aditya Sagar Mandapaka ,  Samuel Jere Marsh ,  Gary A. Morris ,  Subrai Girish Pai ,  Andrew Attila Pal ,  Nicholas Polytaridis ,  Philip Thomas Pupa ,  Eli Reihman ,  Ashley Anne Rindfleisch ,  Sofie Wells Schunk ,  Peter C. Simpson ,  Daniel Smith ,  Stephen J. Vanslyke ,  Matthew T. Vogel ,  Tomas C. Walker ,  Benjamin Elrod West ,  Atiim Joseph Wiley

IPC: A61M5/172 ,  G16H50/20 ,  G06N20/00 ,  A61B5/00 ,  A61B5/024 ,  A61B5/11 ,  A61B5/145 ,  A61B5/16 ,  G08B21/04 ,  H04M1/725 ,  G06N5/04 ,  G16H20/17 ,  G16H40/67 ,  G16H40/63

Abstract: Systems and methods are disclosed that provide smart alerts to users, e.g., alerts to users about diabetic states that are only provided when it makes sense to do so, e.g., when the system can predict or estimate that the user is not already cognitively aware of their current condition, e.g., particularly where the current condition is a diabetic state warranting attention. In this way, the alert or alarm is personalized and made particularly effective for that user. Such systems and methods still alert the user when action is necessary, e.g., a bolus or temporary basal rate change, or provide a response to a missed bolus or a need for correction, but do not alert when action is unnecessary, e.g., if the user is already estimated or predicted to be cognitively aware of the diabetic state warranting attention, or if corrective action was already taken.

公开(公告)号：US09974903B1

公开(公告)日：2018-05-22

申请号：US15582266

申请日：2017-04-28

Applicant: DexCom, Inc.

Inventor： Anna Leigh Davis ,  Arturo Garcia ,  Thomas Hall ,  Hari Hampapuram ,  Christopher Robert Hannemann ,  Anna Claire Harley-Trochimczyk ,  Nathaniel David Heintzman ,  Andrea J. Jackson ,  Lauren Hruby Jepson ,  Apurv Ullas Kamath ,  Katherine Yerre Koehler ,  Scott M. Belliveau ,  Aditya Sagar Mandapaka ,  Samuel Jere Marsh ,  Gary A. Morris ,  Subrai Girish Pai ,  Andrew Attila Pal ,  Nicholas Polytaridis ,  Philip Thomas Pupa ,  Eli Reihman ,  Ashley Anne Rindfleisch ,  Sofie Wells Schunk ,  Naresh C. Bhavaraju ,  Peter C. Simpson ,  Daniel Smith ,  Stephen J. Vanslyke ,  Matthew T. Vogel ,  Tomas C. Walker ,  Benjamin Elrod West ,  Atiim Joseph Wiley ,  Leif N. Bowman ,  Rita M. Castillo ,  Alexandra Elena Constantin ,  Rian Draeger ,  Laura J. Dunn ,  Gary Brian Gable

IPC: A61M5/172 ,  G08B21/04 ,  A61B5/16

CPC classification number: A61B5/746 ,  A61B5/0022 ,  A61B5/024 ,  A61B5/1112 ,  A61B5/14517 ,  A61B5/14532 ,  A61B5/14546 ,  A61B5/165 ,  A61B5/4866 ,  A61B5/742 ,  A61M5/1723 ,  A61M2205/18 ,  A61M2205/3584 ,  A61M2205/50 ,  A61M2205/502 ,  A61M2205/52 ,  A61M2205/581 ,  A61M2205/582 ,  A61M2205/8206 ,  A61M2230/201 ,  G06F19/00 ,  G06F19/3418 ,  G06F19/3468 ,  G06N5/043 ,  G06N99/005 ,  G08B21/0453 ,  G16H20/17 ,  G16H40/67 ,  G16H50/20 ,  H04M1/7253 ,  Y02A90/26

Abstract: Systems and methods are disclosed that provide smart alerts to users, e.g., alerts to users about diabetic states that are only provided when it makes sense to do so, e.g., when the system can predict or estimate that the user is not already cognitively aware of their current condition, e.g., particularly where the current condition is a diabetic state warranting attention. In this way, the alert or alarm is personalized and made particularly effective for that user. Such systems and methods still alert the user when action is necessary, e.g., a bolus or temporary basal rate change, or provide a response to a missed bolus or a need for correction, but do not alert when action is unnecessary, e.g., if the user is already estimated or predicted to be cognitively aware of the diabetic state warranting attention, or if corrective action was already taken.

公开(公告)号：US12289279B2

公开(公告)日：2025-04-29

申请号：US18488898

申请日：2023-10-17

Applicant: Dexcom, Inc.

Inventor： Andrea J. Jackson ,  Subrai Girish Pai ,  Mark Derdzinski ,  Maritza S. Powell ,  Joost Herman Van Der Linden ,  Jessica S. Larrabee

IPC: H04L51/214 ,  G06Q30/0201 ,  G06Q30/0251

Abstract: Certain aspects of the present disclosure relate to methods and systems for optimized delivery of communications including content to users of a software application. The method also includes obtaining, by a customer engagement platform (CEP), a set of cohort selection criteria for identifying a user cohort to deliver the content; identifying, by a data analytics platform (DAP), the user cohort to communicate with in accordance with the set of cohort selection criteria; identifying, by the DAP, one or more communication configurations for communicating with one or more sub-groups within the user cohort; and to each user of the user cohort, transmitting one or more communications based on the content and a corresponding communication configuration for a sub-group that may include the corresponding user; and measuring engagement outcomes associated with usage of the corresponding one or more communication configurations in communication with each of the sub-groups.

公开(公告)号：US20190246914A1

公开(公告)日：2019-08-15

申请号：US16269528

申请日：2019-02-06

Applicant: DexCom, Inc.

Inventor： Alexandra Elena Constantin ,  Scott M. Belliveau ,  Naresh C. Bhavaraju ,  Jennifer Blackwell ,  Eric Cohen ,  Basab Dattaray ,  Anna Leigh Davis ,  Rian Draeger ,  Arturo Garcia ,  John Michael Gray ,  Hari Hampapuram ,  Nathaniel David Heintzmann ,  Lauren Hruby Jepson ,  Matthew Lawrence Johnson ,  Apurv Ullas Kamath ,  Katherine Yerre Koehler ,  Phil Mayou ,  Patrick Wile McBride ,  Michael Robert Mensinger ,  Sumitaka Mikami ,  Andrew Attila Pal ,  Nicholas Polytaridis ,  Philip Thomas Pupa ,  Eli Reihman ,  Peter C. Simpson ,  Tomas C. Walker ,  Daniel Justin Wiedeback ,  Subrai Girish Pai ,  Matthew T. Vogel

IPC: A61B5/0205 ,  A61B5/145 ,  A61B5/00 ,  A61B5/01

CPC classification number: G16H70/20 ,  A61B5/0022 ,  A61B5/1118 ,  A61B5/14532 ,  A61B5/4839 ,  A61B5/486 ,  A61B5/4866 ,  A61B5/7275 ,  A61B5/7282 ,  A61B5/746 ,  G06N5/045 ,  G06N20/00 ,  G16H50/20

Abstract: Systems and methods are provided to provide guidance to a user regarding management of a physiologic condition such as diabetes. The determination may be based upon a patient glucose concentration level. The glucose concentration level may be provided to a stored model to determine a state. The guidance may be determined based at least in part on the determined state.

公开(公告)号：US10052073B2

公开(公告)日：2018-08-21

申请号：US15582467

申请日：2017-04-28

Applicant: DexCom, Inc.

Inventor： Anna Leigh Davis ,  Scott M. Belliveau ,  Naresh C. Bhavaraju ,  Leif N. Bowman ,  Rita M. Castillo ,  Alexandra Elena Constantin ,  Rian Draeger ,  Laura J. Dunn ,  Gary Brian Gable ,  Arturo Garcia ,  Thomas Hall ,  Hari Hampapuram ,  Christopher Robert Hannemann ,  Anna Claire Harley-Trochimczyk ,  Nathaniel David Heintzman ,  Andrea J. Jackson ,  Lauren Hruby Jepson ,  Apurv Ullas Kamath ,  Katherine Yerre Koehler ,  Aditya Sagar Mandapaka ,  Samuel Jere Marsh ,  Gary A. Morris ,  Subrai Girish Pai ,  Andrew Attila Pal ,  Nicholas Polytaridis ,  Philip Thomas Pupa ,  Eli Reihman ,  Ashley Anne Rindfleisch ,  Sofie Wells Schunk ,  Peter C. Simpson ,  Daniel Smith ,  Stephen J. Vanslyke ,  Matthew T. Vogel ,  Tomas C. Walker ,  Benjamin Elrod West ,  Atiim Joseph Wiley

IPC: G08B1/08 ,  A61B5/00 ,  G16H50/20 ,  A61B5/024 ,  A61B5/11 ,  A61B5/145 ,  A61B5/16 ,  G06F19/00 ,  G08B21/04 ,  H04M1/725 ,  G06N5/04 ,  G06N99/00

Abstract: Systems and methods are disclosed that provide smart alerts to users, e.g., alerts to users about diabetic states that are only provided when it makes sense to do so, e.g., when the system can predict or estimate that the user is not already cognitively aware of their current condition, e.g., particularly where the current condition is a diabetic state warranting attention. In this way, the alert or alarm is personalized and made particularly effective for that user. Such systems and methods still alert the user when action is necessary, e.g., a bolus or temporary basal rate change, or provide a response to a missed bolus or a need for correction, but do not alert when action is unnecessary, e.g., if the user is already estimated or predicted to be cognitively aware of the diabetic state warranting attention, or if corrective action was already taken.

公开(公告)号：US20170347971A1

公开(公告)日：2017-12-07

申请号：US15684361

申请日：2017-08-23

Applicant: DexCom, Inc.

Inventor： Anna Leigh Davis ,  Scott M. Belliveau ,  Naresh C. Bhavaraju ,  Leif N. Bowman ,  Rita M. Castillo ,  Alexandra Elena Constantin ,  Rian Draeger ,  Laura J. Dunn ,  Gary Brian Gable ,  Arturo Garcia ,  Thomas Hall ,  Hari Hampapuram ,  Christopher Robert Hannemann ,  Anna Claire Harley-Trochimczyk ,  Nathaniel David Heintzman ,  Andrea J. Jackson ,  Lauren Hruby Jepson ,  Apurv Ullas Kamath ,  Katherine Yerre Koehler ,  Aditya Sagar Mandapaka ,  Samuel Jere Marsh ,  Gary A. Morris ,  Subrai Girish Pai ,  Andrew Attila Pal ,  Nicholas Polytaridis ,  Philip Thomas Pupa ,  Eli Reihman ,  Ashley Anne Rindfleisch ,  Sofie Wells Schunk ,  Peter C. Simpson ,  Daniel Smith ,  Stephen J. Vanslyke ,  Matthew T. Vogel ,  Tomas C. Walker ,  Benjamin Elrod West ,  Atiim Joseph Wiley

IPC: A61B5/00 ,  G08B21/04 ,  A61B5/145 ,  G06N5/04 ,  G06F19/00 ,  A61B5/16 ,  H04M1/725 ,  G06N99/00

Abstract: Systems and methods are disclosed that provide smart alerts to users, e.g., alerts to users about diabetic states that are only provided when it makes sense to do so, e.g., when the system can predict or estimate that the user is not already cognitively aware of their current condition, e.g., particularly where the current condition is a diabetic state warranting attention. In this way, the alert or alarm is personalized and made particularly effective for that user. Such systems and methods still alert the user when action is necessary, e.g., a bolus or temporary basal rate change, or provide a response to a missed bolus or a need for correction, but do not alert when action is unnecessary, e.g., if the user is already estimated or predicted to be cognitively aware of the diabetic state warranting attention, or if corrective action was already taken.

公开(公告)号：US11766194B2

公开(公告)日：2023-09-26

申请号：US16269480

申请日：2019-02-06

Applicant: DexCom, Inc.

Inventor： Alexandra Elena Constantin ,  Scott M. Belliveau ,  Naresh C. Bhavaraju ,  Jennifer Blackwell ,  Eric Cohen ,  Basab Dattaray ,  Anna Leigh Davis ,  Rian Draeger ,  Arturo Garcia ,  John Michael Gray ,  Hari Hampapuram ,  Nathaniel David Heintzman ,  Lauren Hruby Jepson ,  Matthew Lawrence Johnson ,  Apurv Ullas Kamath ,  Katherine Yerre Koehler ,  Phil Mayou ,  Patrick Wile McBride ,  Michael Robert Mensinger ,  Sumitaka Mikami ,  Andrew Attila Pal ,  Nicholas Polytaridis ,  Philip Thomas Pupa ,  Eli Reihman ,  Peter C. Simpson ,  Tomas C. Walker ,  Daniel Justin Wiedeback ,  Subrai Girish Pai ,  Matthew T. Vogel

IPC: A61B5/145 ,  G16H70/20 ,  A61B5/00 ,  G06N20/00 ,  G06N5/045 ,  A61B5/11 ,  A61B5/01 ,  A61B5/0205 ,  G16H50/20 ,  A61B5/024 ,  A61B5/08

CPC classification number: A61B5/14532 ,  A61B5/0022 ,  A61B5/01 ,  A61B5/02055 ,  A61B5/1118 ,  A61B5/486 ,  A61B5/4839 ,  A61B5/4866 ,  A61B5/7221 ,  A61B5/7275 ,  A61B5/7282 ,  A61B5/746 ,  A61B5/7475 ,  G06N5/045 ,  G06N20/00 ,  G16H70/20 ,  A61B5/024 ,  A61B5/0816 ,  G16H50/20

Abstract: Systems and methods are provided to provide guidance to a user regarding management of a physiologic condition such as diabetes. The determination may be based upon a patient glucose concentration level. The glucose concentration level may be provided to a stored model to determine a state. The guidance may be determined based at least in part on the determined state.

公开(公告)号：US20210177317A1

公开(公告)日：2021-06-17

申请号：US17114204

申请日：2020-12-07

Applicant: DexCom, Inc.

Inventor： Andrew Scott Parker ,  Annika Emilie Kristina Jimenez ,  Chad Patterson ,  Subrai Girish Pai ,  Apurv Ullas Kamath

IPC: A61B5/145 ,  A61B5/00 ,  G06N3/08

Abstract: Multi-state engagement with continuous glucose monitoring (CGM) systems is described. Given the number of people that wear CGM systems and because CGM systems produce measurements continuously, a platform that provides a CGM system may have an enormous amount of data. This amount of data is practically, if not actually, impossible for humans to process. In implementations, a CGM platform includes a data analytics platform that obtains packages of glucose measurements provided by a CGM system and also obtains additional data associated with a user. The data analytics platform generates state information for the user by processing these CGM packages and the additional data, at least in part, by using one or more models. Based on this state information, the data analytics platform controls communication with the user, which may include generating intervention strategies to prevent users from transitioning to a negative state such as discontinuing use of the CGM system.